Literature DB >> 29216630

Rapamycin Promotes the Survival and Adipogenesis of Ischemia-Challenged Adipose Derived Stem Cells by Improving Autophagy.

Chichi Li1, Lechi Ye2, Li Yang3, Xiaofang Yu1, Yucang He1, Zhuojie Chen1, Liqun Li1, Dan Zhang3.   

Abstract

BACKGROUND/AIMS: Ischemia is one of the main causes of the high rate of absorption of transplanted autologous fat. Autophagy allows cells to survive by providing energy under starvation. Rapamycin has been found to play a role in promoting autophagy. In this study, we investigated whether rapamycin participates in the survival and adipogenesis of ischemia-challenged adipose-derived stem cells (ADSCs) by regulating autophagy.
METHODS: Before the cells were exposed to oxygen-glucose deprivation (OGD), a simulated ischemic microenvironment, the level of autophagy was reduced or increased by lentiviral transfection with short hairpin RNA targeting microtubule-associated protein 1-light chain 3 gene (shRNA-LC3) or treatment with rapamycin, respectively. The level of autophagy was assessed by western blotting, transmission electron microscopythen the apoptosis ratio was determined through terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and flow cytometry. Adipogenesis was further evaluated by oil red O staining and the expressions level of some specific proteins for adipocytes.
RESULTS: shRNA-LC3 and rapamycin treatment effectively decreased and improved the level of autophagy in cells with or without OGD challenge, respectively. In addition, autophagy inhibition increased the apoptosis rate and activated caspase-3 expression level in response to OGD, and these were markedly inhibited by rapamycin preconditioning. During adipogenesis, autophagy inhibition decreased not only oil droplet accumulation but also lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in cells with or without OGD challenge. However, autophagy promotion by rapamycin increased oil droplet accumulation and LPL and PPARγ expression.
CONCLUSIONS: Rapamycin may promote the survival and adipogenesis of ischemia-challenged ADSCs by upregulating autophagy.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Adipogenesis; Adipose-derived stem cells; Autophagy; Ischemia; Rapamycin

Mesh:

Substances:

Year:  2017        PMID: 29216630     DOI: 10.1159/000485783

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  9 in total

1.  Short-Term Autophagy Preconditioning Upregulates the Expression of COX2 and PGE2 and Alters the Immune Phenotype of Human Adipose-Derived Stem Cells In Vitro.

Authors:  Rachel M Wise; Sara Al-Ghadban; Mark A A Harrison; Brianne N Sullivan; Emily R Monaco; Sarah J Aleman; Umberto M Donato; Bruce A Bunnell
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

2.  Rapamycin and 3-Methyladenine Influence the Apoptosis, Senescence, and Adipogenesis of Human Adipose-Derived Stem Cells by Promoting and Inhibiting Autophagy: An In Vitro and In Vivo Study.

Authors:  Fan Yang; Le Du; Guodong Song; Xianlei Zong; Xiaolei Jin; Xiaonan Yang; Zuoliang Qi
Journal:  Aesthetic Plast Surg       Date:  2021-01-11       Impact factor: 2.708

3.  Autophagy regulates the therapeutic potential of adipose-derived stem cells in LPS-induced pulmonary microvascular barrier damage.

Authors:  Chichi Li; Jingye Pan; Lechi Ye; Honglei Xu; Beibei Wang; Hanyan Xu; Lingna Xu; Tongtong Hou; Dan Zhang
Journal:  Cell Death Dis       Date:  2019-10-23       Impact factor: 8.469

4.  Ischemia-Like Stress Conditions Stimulate Trophic Activities of Adipose-Derived Stromal/Stem Cells.

Authors:  Julia Bachmann; Elias Ehlert; Matthias Becker; Christoph Otto; Katrin Radeloff; Torsten Blunk; Petra Bauer-Kreisel
Journal:  Cells       Date:  2020-08-21       Impact factor: 6.600

5.  Effects of shRNA-mediated silencing of PDE5A3 on intracellular cGMP and free Ca2+ levels and human prostate smooth muscle cell proliferation from benign prostatic hyperplasia.

Authors:  Zheng Xu; Yuzheng Ge; Ke Jiang; Luwei Xu; Jiageng Zhu; Changcheng Zhou; Liuhua Zhou; Ruipeng Jia
Journal:  Exp Ther Med       Date:  2021-02-05       Impact factor: 2.447

6.  Deciphering the Emerging Roles of Adipocytes and Adipose-Derived Stem Cells in Fat Transplantation.

Authors:  Yi Yi; Weijie Hu; Chongru Zhao; Min Wu; Hong Zeng; Mingchen Xiong; Wenchang Lv; Yiping Wu; Qi Zhang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

7.  SVIP alleviates CCl4-induced liver fibrosis via activating autophagy and protecting hepatocytes.

Authors:  Dan Jia; Yuan Yuan Wang; Pin Wang; Yao Huang; David Yuke Liang; Dongmei Wang; Chuandong Cheng; Caihua Zhang; Lianying Guo; Pin Liang; Yang Wang; Yujie Jia; Cong Li
Journal:  Cell Death Dis       Date:  2019-01-25       Impact factor: 8.469

8.  Connexin 43‑autophagy loop in the podocyte injury of diabetic nephropathy.

Authors:  Jialing Ji; Yajie Zhao; Chen Na; Min Yang; Xianyi Zhu; Huimin Shi; Weihua Gan; Aiqing Zhang
Journal:  Int J Mol Med       Date:  2019-09-10       Impact factor: 4.101

9.  Short-Term Rapamycin Preconditioning Diminishes Therapeutic Efficacy of Human Adipose-Derived Stem Cells in a Murine Model of Multiple Sclerosis.

Authors:  Rachel M Wise; Mark A A Harrison; Brianne N Sullivan; Sara Al-Ghadban; Sarah J Aleman; Amber T Vinluan; Emily R Monaco; Umberto M Donato; India A Pursell; Bruce A Bunnell
Journal:  Cells       Date:  2020-09-30       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.